No Detail Found!

Subtenon vs intravitreal triamcinolone injection in diabetic macular edema: A prospective study in Chinese population.

Author(s)
Dawei Luo Department of Ophthalmology, Shanghai First People’s Hospital, Shanghai, 200080, China;Nanjing Medical University, Nanjing, Jiangsu Province, China
Bijun Zhu Department of Ophthalmology, Shanghai First People’s Hospital, Shanghai, China
Zhizheng Department of Ophthalmology, Shanghai First People’s Hospital, Shanghai, China
Haidong Zhou Department of Ophthalmology, Shanghai First People’s Hospital, Shanghai, China
Xiaodong Sun Department of Ophthalmology, Shanghai First People’s Hospital, Shanghai, China
Xun Xu Nanjing Medical University, Nanjing, Jiangsu Province, No.140 Hanzhong Road, China
Abstract
Objective: Purpose of this study was to validate that Subtenon (SB) Triamcinolone (TA) injection is an alternative to Intravitreal (IV) Triamcinolone (TA) injection for the treatment of diabetic macular edema (DME). Methods: Forty eyes were selected having DME due to type 1 or type 2 diabetes. All the patients were treated with photocoagulation. IVTA was administered in one eye and SBTA in following eye of same patient. Improvement in visual acuity, macular edema and intraocular pressure was assessed before treatment and on 2nd, 4th, 8th and 12th week after treatment. Results: After administration of IVTA, MVA was reduced from baseline value (0.805 ± 0.069Log/MAR) to (0.577 ± 0.091 Log/MAR, p Conclusion: Subtenon Triamcinolone injection is an alternative to Intravitreal Triamcinolone Injection for Diabetic Macular Edema.
Publication Details
Page(s) 749-754
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 30, Issue: 4, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

84

Views